CELESTICA INC (CLS) Stock Analyst Ratings
USA - NYSE:CLS - CA15101Q2071 - Common Stock
282.73 USD
+11.84 (+4.37%)
292.03 USD
+9.3 (+3.29%)
ChartMill assigns a Buy % Consensus number of 81% to CLS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 161.12. This target is -43.01% below the current price.
CLS was analyzed by 16 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CLS.
In the previous month the buy percentage consensus was at a similar level.
CLS was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-22 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | CIBC | Maintains | Outperformer -> Outperformer |
| 2025-10-16 | Goldman Sachs | Initiate | Buy |
| 2025-10-03 | TD Cowen | Reiterate | Hold |
| 2025-10-03 | TD Securities | Downgrade | Buy -> Hold |
| 2025-09-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-19 | CICC | Initiate | Outperform |
| 2025-07-30 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-30 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-21 | Citigroup | Initiate | Neutral |
| 2025-07-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-06-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-22 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-04-29 | Argus Research | Maintains | Buy -> Buy |
| 2025-04-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-15 | CIBC | Maintains | Outperformer -> Outperformer |
| 2025-02-19 | Stifel | Maintains | Buy -> Buy |
| 2025-02-13 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-01-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-01-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-28 | TD Securities | Maintains | Buy -> Buy |
| 2025-01-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-12-10 | Stifel | Maintains | Buy -> Buy |